Cuu Long Pharmaceutical JSC (HOSE:DCL)

Vietnam flag Vietnam · Delayed Price · Currency is VND
41,000
-500 (-1.20%)
At close: Dec 5, 2025
49.09%
Market Cap 2.99T
Revenue (ttm) 1.46T
Net Income (ttm) 35.78B
Shares Out 73.04M
EPS (ttm) 489.47
PE Ratio 83.76
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 616,668
Average Volume 1,075,037
Open 41,000
Previous Close 41,500
Day's Range 39,200 - 41,400
52-Week Range 19,000 - 42,500
Beta 0.78
RSI 76.74
Earnings Date Jan 27, 2026

About HOSE:DCL

Cuu Long Pharmaceutical Joint Stock Company produces drugs, chemicals, and medicines in Vietnam. It offers antiallergy, pain reliever and fever reducer, antibiotic, anti-inflammatory, antiviral, cardiovascular, corticosteroid, cough, dermatology, digestive, nervous system, musculoskeletal, and vitamin and mineral medicines, as well as capsules and medical equipment. The company is also involved in retailing drugs, medical devices, and cosmetics, as well as trades in pharmaceuticals and medical equipment. It sells its products to hospitals, phar... [Read more]

Industry Pharmaceutical Preparations
Founded 1976
Employees 885
Stock Exchange Ho Chi Minh Stock Exchange
Ticker Symbol DCL
Full Company Profile

Financial Performance

In 2024, HOSE:DCL's revenue was 1.31 trillion, an increase of 14.24% compared to the previous year's 1.14 trillion. Earnings were 53.57 billion, a decrease of -10.29%.

Financial Statements

News

There is no news available yet.